Cargando…

1472. Antibiotic De-escalation Compared with Continued Empirical Treatment in Non-Ventilated Hospital-Acquired Pneumonia

BACKGROUND: Antibiotic de-escalation is an important component of antimicrobial stewardship programs. Nosocomial pneumonia is the most common healthcare-associated infection with nonventilated hospital-acquired pneumonia (HAP) comprising the majority of cases. We aimed to compare antibiotic de-escal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alnaimi, Shaikha, Rawson, Timothy, Holmes, Alison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252463/ http://dx.doi.org/10.1093/ofid/ofy210.1302

Ejemplares similares

1472 Epidemiology of Meningitis in an HIV-infected Ugandan Cohort
por: Rajasingham, Radha, et al.
Publicado: (2014)

Nezahualcóyotl, Acolmiztli, 1402-1472
por: Alva Ixtlilxóchitl, Fernando de, 1402-1472
Publicado: (1972)

Empiric antibiotic therapy for ventilator-associated pneumonia: a systematic review of the evidence
por: Aarts, MW, et al.
Publicado: (2003)

1459. Association of Antibiotic Prophylaxis Duration and Length of Stay in Patients Undergoing Coronary Artery Bypass Graft Procedure
por: Alnaimi, Shaikha, et al.
Publicado: (2023)

Use of MRSA Nasal Swab to Guide Empiric Antibiotic Treatment of Hospital Acquired or Community Acquired Pneumonia in a Pediatric Population
por: Linfesty, Daniel, et al.
Publicado: (2017)

Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia
por: Swanson, Joseph M., et al.
Publicado: (2013)

Impact of an Emergency Medicine Pharmacist on Appropriate Empiric Antibiotic Prescribing for Community-Acquired Pneumonia and Intra-Abdominal Infections
por: Kulwicki, Benjamin, et al.
Publicado: (2017)

2724. Community-acquired Pneumonia in Immunocompromised Patients: Predictors and Outcomes Associated with Empiric Broad-spectrum Antibiotic Treatment
por: Saravolatz, Louis, et al.
Publicado: (2023)

354. A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) Caused by Gram-Negative Bacteria in Intensive Care Units (ICU)
por: Wangchinda, Walaiporn, et al.
Publicado: (2023)

1090. Practicing Antimicrobial Stewardship: De-escalating Empiric Antibiotics in Patients with Acute Myelogenous Leukemia and Neutropenic Fever
por: Fuller, Risa, et al.
Publicado: (2019)

Lack of pathogen identification influencing antibiotic de-escalation in hospital-acquired pneumonia
por: Bittmann, Matthew C., et al.
Publicado: (2022)

De-escalation of Broad Spectrum Antibiotics Following Negative Cultures in Pneumonia: Rates and Outcomes
por: Deshpande, Abhishek, et al.
Publicado: (2017)

166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU
por: Schooneveld, Trevor C Van, et al.
Publicado: (2023)

1472. Development of an Interactive Provider Dashboard for Enhanced Recovery After Surgery to Monitor Compliance with Perioperative Surgical Site Infection Measures
por: Patel, Pratish C, et al.
Publicado: (2023)

Challenges of Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Children
por: Rodrigues, Charlene M.C.
Publicado: (2017)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
por: Jung, Yun Jung, et al.
Publicado: (2022)

1472. Non-Carbapenems for Treating Community-Associated Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Children
por: Joo Jung, Hyun, et al.
Publicado: (2019)

66. Impact of a Pharmacist-Driven Azithromycin De-escalation Protocol for Community-Acquired Pneumonia
por: Shakeraneh, Pegah, et al.
Publicado: (2020)

1319. Assessment of Spectrum Score-Based Antibiotic De-Escalation in Patients with Nosocomial Pneumonia
por: Ilges, Daniel T, et al.
Publicado: (2021)

1476. Objective Surveillance Definitions for Hospital-Acquired Pneumonia in Non-Ventilated Patients
por: Ji, Wenjing, et al.
Publicado: (2018)

PReS13-SPK-1472: Science of muscle training in inflammatory disease
por: Van Brussel, M
Publicado: (2013)

Antibiotic Prescribing for Pediatric Community-Acquired Pneumonia at Children’s Hospitals and General Hospitals Following National Guideline Release
por: Tribble, Alison, et al.
Publicado: (2017)

1646. Optimizing Antibiotic Durations of Therapy in Pediatric Community-acquired Pneumonia
por: Cook, Gregory, et al.
Publicado: (2023)

P24 Auditing antibiotic course lengths for the management of community-acquired pneumonia and hospital-acquired pneumonia against current NICE guidance
por: Chua, Elaine, et al.
Publicado: (2023)

1472. Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated from Patients Hospitalized with Bacterial Pneumonia in the United States, Western Europe, and Eastern Europe: Results from the SENTRY Program (2016-2019)
por: Sader, Helio S, et al.
Publicado: (2020)

869. Evaluation of Broad-Spectrum Antibiotic De-Escalation in Patients with Health-Care Associated Pneumonia (HCAP) and No Microbiological Diagnosis
por: Patel, Twisha S, et al.
Publicado: (2018)

Empiric antibiotic selection for community-acquired pneumonia in US hospitals, 2013–2020
por: Wolford, Hannah, et al.
Publicado: (2023)

879. Intravenous to Oral Antibiotic Switch in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2022)

De-escalation of empiric antibiotic therapy in sepsis - an indian observational study
por: Jakkinaboina, S, et al.
Publicado: (2015)

2599. Impact of Alveolar Neutrophilia on Outcomes in Patients with Suspected Ventilated Hospital-Acquired Bacterial Pneumonia
por: Saravolatz, Louis, et al.
Publicado: (2023)

PO-1472 OnCovid!: a project to ensure continuity and adequate quality of oncological care during the COVID-19 pandemic
por: Verheij, M., et al.
Publicado: (2021)

1215. The Impact of MRSA Nasal PCR on Antibiotic De-escalation
por: Silverman, Adam, et al.
Publicado: (2023)

272. Clinical Outcomes with Continuation of Combination Antibiotic Therapy versus De-escalation to Monotherapy for Patients with MRSA Bacteremia
por: Nichols, Courtney, et al.
Publicado: (2020)

93. Enhanced Oral Care as Prevention for Non-ventilator Hospital Acquired Pneumonia
por: Giuliano, Karen K, et al.
Publicado: (2020)

1477. Impact Of Resistance Thresholds On Mortality In Hospital-Acquired And Ventilator-Associated Pneumonia
por: Mazi, Patrick B, et al.
Publicado: (2020)

1224. Outcomes of Empirical Vancomycin De-escalation Based on Methicillin-Resistant Staphylococcus aureus Nares
por: Xu, Jiachen, et al.
Publicado: (2023)

De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia
por: Rearigh, Lindsey, et al.
Publicado: (2020)

2190. Influence of Microbiological Culture Results on Antibiotic Choice for Veterans with Hospital-Acquired Pneumonia
por: Lee Anne. Christian, Robbie, et al.
Publicado: (2019)

Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia
por: Khasawneh, Faisal A, et al.
Publicado: (2014)

Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Motowski, Hayley, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vq6lhodhs02bj6hkvphcrd1oge